MW

Mohammad Waseem Vakil Mansoori

Active Director Director DIN 10595696
DIN 10595696 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Waseem Vakil Mansoori

Data last updated:

Mohammad Waseem Vakil Mansoori is a Director at Milorin Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10595696
Primary Designation Director
Industry Paper
First Appointment 18 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Milorin Pharma Private Limited U21000MH2024PTC423676
Director18 Apr 20242024Active

Board colleagues of Mohammad Waseem Vakil Mansoori

NameDINCompanyDesignation
Mohammad Naseem Vakil Mansoori10595697Milorin Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Milorin Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammad Waseem Vakil Mansoori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Waseem Vakil Mansoori

Mohammad Waseem Vakil Mansoori currently holds 1 directorship: Milorin Pharma Private Limited (Director, since 18 Apr 2024).

Mohammad Waseem Vakil Mansoori was first appointed on 18 Apr 2024 as Director at Milorin Pharma Private Limited.

The current boards of Mohammad Waseem Vakil Mansoori's companies include Mohammad Naseem Vakil Mansoori (Milorin Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available